glycocyamine has been researched along with Multiple Sclerosis in 1 studies
glycocyamine: RN given refers to parent cpd; structure
guanidinoacetate : A monocarboxylic acid anion that is the conjugate base of guanidinoacetic acid, obtained by deprotonation of the carboxy group.
guanidinoacetic acid : The N-amidino derivative of glycine.
Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute secondary progressive multiple sclerosis (SPMS) is characterized by escalating neurological disability, with limited disease-modifying therapeutic options." | 5.72 | Guanidinoacetate-creatine in secondary progressive multiple sclerosis: a case report. ( Jezdimirovic, T; Ostojic, J; Ostojic, SM; Stajer, V; Zanini, D, 2022) |
| "Acute secondary progressive multiple sclerosis (SPMS) is characterized by escalating neurological disability, with limited disease-modifying therapeutic options." | 1.72 | Guanidinoacetate-creatine in secondary progressive multiple sclerosis: a case report. ( Jezdimirovic, T; Ostojic, J; Ostojic, SM; Stajer, V; Zanini, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ostojic, SM | 1 |
| Ostojic, J | 1 |
| Zanini, D | 1 |
| Jezdimirovic, T | 1 |
| Stajer, V | 1 |
1 other study available for glycocyamine and Multiple Sclerosis
| Article | Year |
|---|---|
Guanidinoacetate-creatine in secondary progressive multiple sclerosis: a case report.
Topics: Creatine; Female; Glycine; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; | 2022 |